ARTICLE | Clinical News
CGC-11047: Phase Ib started
October 9, 2006 7:00 AM UTC
Cellgate began a dose-escalation Phase Ib trial in about 70 patients with advanced cell malignancies or lymphomas. The trial will measure the pharmacokinetics and anti-tumor activity of weekly IV dose...